How Siokas was paid
$2.9M in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Other | Total |
|---|---|---|---|---|---|
| Grigorios SiokasChairman and Chief Executive Officer | $1,080,000 | $400,000 | $1,242,100 | — | $2,904,100 |
| Georgios TerzisChief Financial Officer | $166,698 | $100,000 | $494,900 | — | $761,898 |
| Nikolaos BardakisChief Operating Officer | $22,722 | $15,000 | $35,350 | $15,071 | $88,143 |
| Suhel BhutawalaCommercial Director, Decahedron Ltd. | $84,357 | $25,250 | $10,000 | — | $119,607 |
What changed and why
- $2.904M$2.904M CEO total compensation in 2024, versus $2.880M in 2023.
- $1.242M$1.242M CEO stock awards were reported for 2024.
- $850K$850,042 was reported as average non-PEO NEO compensation for 2024.
- 3.5M3.5 million shares were reserved under the 2024 Omnibus Equity Incentive Plan.
- No pension, retirement, or similar benefits are provided to executive officers.
- No financial performance measures were used to link 2024 NEO compensation.
Other Cosmos Health proxy statements
- 2026 proxy statement
Grigorios Siokas paid $3.6M (+22% on the year).
Filed Jun 02, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.